AAAAAA

   
Results: 1-16 |
Results: 16
Functional properties of factor V and factor Va encoded by the R2-gene
Authors: Hoekema, L Castoldi, E Tans, G Girelli, D Gemmati, D Bernardi, F Rosing, J
Citation: L. Hoekema et al., Functional properties of factor V and factor Va encoded by the R2-gene, THROMB HAEM, 85(1), 2001, pp. 75-81
Oral contraceptives, thrombosis and haemostasis
Authors: Rosing, J Curvers, J Tans, G
Citation: J. Rosing et al., Oral contraceptives, thrombosis and haemostasis, EUR J OB GY, 95(2), 2001, pp. 193-197
Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent
Authors: Briede, JJ Tans, G Willems, GM Hemker, HC Lindhout, T
Citation: Jj. Briede et al., Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent, J BIOL CHEM, 276(10), 2001, pp. 7164-7168
Effect of in vitro fertilization treatment and subsequent pregnancy on theprotein C pathway
Authors: Curvers, J Nap, AW Thomassen, MCLGD Nienhuis, SJ Hamulyak, K Evers, JLH Tans, G Rosing, J
Citation: J. Curvers et al., Effect of in vitro fertilization treatment and subsequent pregnancy on theprotein C pathway, BR J HAEM, 115(2), 2001, pp. 400-407
Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity
Authors: Sere, KM Janssen, MP Willems, GM Tans, G Rosing, J Hackeng, TM
Citation: Km. Sere et al., Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity, BIOCHEM, 40(30), 2001, pp. 8852-8860
An assay to quantify the two plasma isoforms of Factor V
Authors: Hoekema, L Rosing, J Tans, G
Citation: L. Hoekema et al., An assay to quantify the two plasma isoforms of Factor V, THROMB HAEM, 84(6), 2000, pp. 1066-1071
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study
Authors: Middeldorp, S Meijers, JCM van den Ende, AE van Enk, A Bouma, BN Tans, G Rosing, J Prins, MH Buller, HR
Citation: S. Middeldorp et al., Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study, THROMB HAEM, 84(1), 2000, pp. 4-8
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis - A randomized cross-over study of two low-dose oral contraceptives
Authors: Meijers, JCM Middeldorp, S Tekelenburg, W van den Ende, AE Tans, G Prins, MH Rosing, J Buller, HR Bouma, BN
Citation: Jcm. Meijers et al., Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis - A randomized cross-over study of two low-dose oral contraceptives, THROMB HAEM, 84(1), 2000, pp. 9-14
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways
Authors: Tans, G Curvers, J Middeldorp, S Thomassen, MCLGD Meijers, JCM Prins, MH Bouma, BN Buller, HR Rosing, J
Citation: G. Tans et al., A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways, THROMB HAEM, 84(1), 2000, pp. 15-21
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma
Authors: Castoldi, E Rosing, J Girelli, D Hoekema, L Lunghi, B Mingozzi, F Ferraresi, P Friso, S Corrocher, R Tans, G Bernardi, F
Citation: E. Castoldi et al., Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma, THROMB HAEM, 83(3), 2000, pp. 362-365
C4b-binding protein protects coagulation factor Va from inactivation by activated protein C
Authors: van de Poel, RHL Meijers, JCM Rosing, J Tans, G Bouma, BN
Citation: Rhl. Van De Poel et al., C4b-binding protein protects coagulation factor Va from inactivation by activated protein C, BIOCHEM, 39(47), 2000, pp. 14543-14548
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study
Authors: Rosing, J Middeldorp, S Curvers, J Thomassen, MCLGD Nicolaes, GAF Meijers, JCM Bouma, BN Buller, HR Prins, MH Tans, G
Citation: J. Rosing et al., Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study, LANCET, 354(9195), 1999, pp. 2036-2040
C-terminal residues 621-635 of protein S are essential for binding to factor Va
Authors: Heeb, MJ Kojima, Y Rosing, J Tans, G Griffin, JH
Citation: Mj. Heeb et al., C-terminal residues 621-635 of protein S are essential for binding to factor Va, J BIOL CHEM, 274(51), 1999, pp. 36187-36192
Acquired APC resistance and oral contraceptives: differences between two functional tests
Authors: Curvers, J Thomassen, MCLGD Nicolaes, GAF van Oerle, R Hamulyak, K Hemker, HC Tans, G Rosing, J
Citation: J. Curvers et al., Acquired APC resistance and oral contraceptives: differences between two functional tests, BR J HAEM, 105(1), 1999, pp. 88-94
Effects of oral contraceptives on hemostasis and thrombosis
Authors: Rosing, J Tans, G
Citation: J. Rosing et G. Tans, Effects of oral contraceptives on hemostasis and thrombosis, AM J OBST G, 180(6), 1999, pp. S375-S382
Molecular biology and pathophysiology of APC resistance: Current insights and clinical implications
Authors: Rosing, J Hemker, HC Tans, G
Citation: J. Rosing et al., Molecular biology and pathophysiology of APC resistance: Current insights and clinical implications, SEM THROMB, 24(4), 1998, pp. 329-335
Risultati: 1-16 |